Fate of Breast Implant Reapproval Still in Doubt
The media gave it scant play, but this article from last Thursday's Washington Post reports that the decision on FDA reapproval of silicone breast implants may not be so final as it first seemed. Last month, an FDA advisory panel voted 9-6 to recommend reapproval. But it now transpires that the panel's chairman (who, pursuant to FDA rules, did not vote) has written a letter to FDA Commissioner Mark McClellan, urging that the advisory panel's vote was misguided and should be rejected. Among the points raised by opponents of reapproval: every plastic surgeon on the panel voted in favor of permitting the implants.
<< Home